Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML)

Imatinib (Gleevec; STI-571) is a tyrosine-kinase inhibitor (TKI) used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most common adverse effects with imatinib include s...

Full description

Saved in:
Bibliographic Details
Published in:Cureus
Main Authors: El Jurdi, Najla, Bankoff, Mark, Klein, Andreas, Saif, Muhammad W
Format: Artigo
Language:Inglês
Published: Cureus 2016
Subjects:
General Surgery
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963232/
https://ncbi.nlm.nih.gov/pubmed/27489753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.660
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items